Arturo LoAIza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio, shared a post on LinkedIn:
“Full day of CME discussing the top research from ASCOGI25 and practice changing studies for our patients with gastrointestinal malignancies. Thank you American Society of Clinical Oncology (ASCO) and Total Health Oncology.”
